Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

AMBS has the potential catalysis to meet that challenge. It will simply take one institutional investor to see the value in ESS. I can honestly see AMBS announcing the closing of that acquisition, federal grant money being allocated to perform the Phase 2 trial and it's off to the races. The market cap could easily double from here on that alone.

Through in continued news on Eltro Phase 2 trail progression and much awaited LymPro data to be release at the AAIC conference in mid July and the PPS could reach Jason N valuation price.

These things come to fruition over the next 7.5 weeks. I believe GC is aware he needs to deliver now.